Serum sTREM-1 in adult-onset Still’s disease: a novel biomarker of disease activity and a potential predictor of the chronic course

Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease

(2019) Bram Verstockt et al.   EBioMedicine

In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis

(2019) Clémence Gorlier et al.   Innate Immunity

Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock

(2018) Lucie Jolly et al.   CARDIOVASCULAR RESEARCH

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD

(2018) Renaud Gaujoux et al.   GUT

Mechanisms, biomarkers and targets for adult-onset Still’s disease

(2018) Eugen Feist et al.   Nature Reviews Rheumatology

TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives

(2017) Alessandra Tammaro et al.   PHARMACOLOGY & THERAPEUTICS

Elevated high-mobility group B1 levels in active adult-onset Still’s disease associated with systemic score and skin rash

(2016) Ju-Yang Jung et al.   CLINICAL RHEUMATOLOGY

Clinical Association of a Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Patients with Systemic Lupus Erythematosus

(2016) Iman H. Bassyouni et al.   IMMUNOLOGICAL INVESTIGATIONS

Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis

(2015) Yair Molad et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Adult onset Still's disease (AOSD) in the era of biologic therapies: Dichotomous view for cytokine and clinical expressions

(2014) Alexandre Thibault Jacques Maria et al.   AUTOIMMUNITY REVIEWS

Adult-onset Still's disease

(2014) Mathieu Gerfaud-Valentin et al.   AUTOIMMUNITY REVIEWS

Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart

(2014) Yvan Jamilloux et al.   IMMUNOLOGIC RESEARCH

Clinical Manifestations of Adult-Onset Still's Disease Presenting With Erosive Arthritis: Association With Low Levels of Ferritin and Interleukin-18

(2013) Hisae Ichida et al.   ARTHRITIS CARE & RESEARCH

Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease

(2013) Der-Yuan Chen et al.   ARTHRITIS RESEARCH & THERAPY

The Proinflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma

(2012) Juan Wu et al.   CANCER RESEARCH

Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases

(2012) Yoon Suk Jung et al.   DIGESTIVE AND LIVER DISEASE

Natural Killer Cell Cytolytic Function in Korean Patients with Adult-onset Still's Disease

(2012) J. H. PARK et al.   JOURNAL OF RHEUMATOLOGY

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) D. Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease

(2010) Stefano Franchini et al.   ARTHRITIS AND RHEUMATISM

Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis

(2010) M. Shimizu et al.   RHEUMATOLOGY

Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis

(2009) Yousuke Murakami et al.   ARTHRITIS AND RHEUMATISM

Correlation of Serum-Soluble Triggering Receptor Expressed on Myeloid Cells-1 with Clinical Disease Activity in Inflammatory Bowel Disease

(2008) Jae Jun Park et al.   DIGESTIVE DISEASES AND SCIENCES

The TREM-1/DAP12 pathway

(2008) Anja S. Tessarz et al.   IMMUNOLOGY LETTERS